nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—skin cancer—melanoma	0.41	0.544	CtDrD
Bleomycin—germ cell cancer—melanoma	0.343	0.456	CtDrD
Bleomycin—BLMH—hair follicle—melanoma	0.00632	0.176	CbGeAlD
Bleomycin—Radiation pneumonitis—Docetaxel—melanoma	0.00499	0.0629	CcSEcCtD
Bleomycin—Lung fibrosis interstitial—Carmustine—melanoma	0.00485	0.0611	CcSEcCtD
Bleomycin—LIG1—eye—melanoma	0.00391	0.109	CbGeAlD
Bleomycin—Hyperkeratosis—Vemurafenib—melanoma	0.0037	0.0466	CcSEcCtD
Bleomycin—LIG1—skin of body—melanoma	0.0034	0.0944	CbGeAlD
Bleomycin—BLMH—retina—melanoma	0.00313	0.0869	CbGeAlD
Bleomycin—Skin toxicity—Docetaxel—melanoma	0.00312	0.0393	CcSEcCtD
Bleomycin—LIG1—mammalian vulva—melanoma	0.0031	0.0861	CbGeAlD
Bleomycin—LIG1—Paclitaxel—Docetaxel—melanoma	0.00284	1	CbGdCrCtD
Bleomycin—BLMH—skin of body—melanoma	0.00275	0.0763	CbGeAlD
Bleomycin—Scleroderma—Docetaxel—melanoma	0.00265	0.0335	CcSEcCtD
Bleomycin—BLMH—mammalian vulva—melanoma	0.0025	0.0696	CbGeAlD
Bleomycin—Nail changes—Docetaxel—melanoma	0.00248	0.0312	CcSEcCtD
Bleomycin—LIG3—head—melanoma	0.0024	0.0666	CbGeAlD
Bleomycin—LIG1—head—melanoma	0.00222	0.0616	CbGeAlD
Bleomycin—BLMH—head—melanoma	0.00179	0.0498	CbGeAlD
Bleomycin—LIG3—lymph node—melanoma	0.00168	0.0466	CbGeAlD
Bleomycin—LIG1—lymph node—melanoma	0.00155	0.0431	CbGeAlD
Bleomycin—Myelosuppression—Dactinomycin—melanoma	0.00127	0.0161	CcSEcCtD
Bleomycin—Pulmonary fibrosis—Carmustine—melanoma	0.00127	0.016	CcSEcCtD
Bleomycin—BLMH—lymph node—melanoma	0.00125	0.0348	CbGeAlD
Bleomycin—Pulmonary fibrosis—Temozolomide—melanoma	0.00123	0.0155	CcSEcCtD
Bleomycin—Lung infiltration—Carmustine—melanoma	0.00119	0.015	CcSEcCtD
Bleomycin—Myelosuppression—Carmustine—melanoma	0.00119	0.015	CcSEcCtD
Bleomycin—Myelosuppression—Temozolomide—melanoma	0.00115	0.0145	CcSEcCtD
Bleomycin—Febrile neutropenia—Dactinomycin—melanoma	0.000993	0.0125	CcSEcCtD
Bleomycin—Nephropathy toxic—Carmustine—melanoma	0.000973	0.0123	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Carmustine—melanoma	0.00094	0.0118	CcSEcCtD
Bleomycin—Febrile neutropenia—Carmustine—melanoma	0.000929	0.0117	CcSEcCtD
Bleomycin—Febrile neutropenia—Temozolomide—melanoma	0.000898	0.0113	CcSEcCtD
Bleomycin—Pulmonary fibrosis—Docetaxel—melanoma	0.000817	0.0103	CcSEcCtD
Bleomycin—Interstitial lung disease—Carmustine—melanoma	0.00079	0.00995	CcSEcCtD
Bleomycin—Arthritis—Vemurafenib—melanoma	0.000789	0.00995	CcSEcCtD
Bleomycin—Myelosuppression—Docetaxel—melanoma	0.000766	0.00965	CcSEcCtD
Bleomycin—Interstitial lung disease—Temozolomide—melanoma	0.000763	0.00962	CcSEcCtD
Bleomycin—Hyperaesthesia—Temozolomide—melanoma	0.000688	0.00867	CcSEcCtD
Bleomycin—Extravasation—Dactinomycin—melanoma	0.000684	0.00863	CcSEcCtD
Bleomycin—Mucosal inflammation—Docetaxel—melanoma	0.000649	0.00818	CcSEcCtD
Bleomycin—Extravasation—Carmustine—melanoma	0.000641	0.00807	CcSEcCtD
Bleomycin—Ulcer—Dactinomycin—melanoma	0.000631	0.00796	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Docetaxel—melanoma	0.000604	0.00761	CcSEcCtD
Bleomycin—Weight decreased—Vemurafenib—melanoma	0.0006	0.00756	CcSEcCtD
Bleomycin—Febrile neutropenia—Docetaxel—melanoma	0.000597	0.00753	CcSEcCtD
Bleomycin—Nail disorder—Docetaxel—melanoma	0.000554	0.00698	CcSEcCtD
Bleomycin—Skin exfoliation—Carmustine—melanoma	0.000534	0.00673	CcSEcCtD
Bleomycin—Skin exfoliation—Temozolomide—melanoma	0.000516	0.0065	CcSEcCtD
Bleomycin—Interstitial lung disease—Docetaxel—melanoma	0.000507	0.0064	CcSEcCtD
Bleomycin—Phlebitis—Dactinomycin—melanoma	0.000503	0.00634	CcSEcCtD
Bleomycin—Chills—Vemurafenib—melanoma	0.000476	0.006	CcSEcCtD
Bleomycin—Phlebitis—Carmustine—melanoma	0.000471	0.00594	CcSEcCtD
Bleomycin—Alopecia—Vemurafenib—melanoma	0.000469	0.00591	CcSEcCtD
Bleomycin—Erythema—Vemurafenib—melanoma	0.000462	0.00582	CcSEcCtD
Bleomycin—Injury—Carmustine—melanoma	0.000441	0.00556	CcSEcCtD
Bleomycin—Extravasation—Docetaxel—melanoma	0.000412	0.00519	CcSEcCtD
Bleomycin—Cough—Vemurafenib—melanoma	0.000403	0.00508	CcSEcCtD
Bleomycin—Myalgia—Vemurafenib—melanoma	0.000393	0.00496	CcSEcCtD
Bleomycin—Anaphylactic shock—Vemurafenib—melanoma	0.000377	0.00475	CcSEcCtD
Bleomycin—Infection—Vemurafenib—melanoma	0.000375	0.00472	CcSEcCtD
Bleomycin—Pancytopenia—Dactinomycin—melanoma	0.000356	0.00448	CcSEcCtD
Bleomycin—Hypotension—Vemurafenib—melanoma	0.000352	0.00444	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000344	0.00433	CcSEcCtD
Bleomycin—Skin exfoliation—Docetaxel—melanoma	0.000343	0.00432	CcSEcCtD
Bleomycin—Pneumonia—Dactinomycin—melanoma	0.000336	0.00423	CcSEcCtD
Bleomycin—Pancytopenia—Carmustine—melanoma	0.000333	0.0042	CcSEcCtD
Bleomycin—Decreased appetite—Vemurafenib—melanoma	0.000328	0.00413	CcSEcCtD
Bleomycin—Stomatitis—Dactinomycin—melanoma	0.000326	0.0041	CcSEcCtD
Bleomycin—Pancytopenia—Temozolomide—melanoma	0.000322	0.00406	CcSEcCtD
Bleomycin—Pneumonia—Carmustine—melanoma	0.000314	0.00396	CcSEcCtD
Bleomycin—Weight decreased—Temozolomide—melanoma	0.000307	0.00386	CcSEcCtD
Bleomycin—Stomatitis—Carmustine—melanoma	0.000305	0.00384	CcSEcCtD
Bleomycin—Pneumonia—Temozolomide—melanoma	0.000304	0.00383	CcSEcCtD
Bleomycin—Phlebitis—Docetaxel—melanoma	0.000303	0.00381	CcSEcCtD
Bleomycin—Body temperature increased—Vemurafenib—melanoma	0.000298	0.00376	CcSEcCtD
Bleomycin—Stomatitis—Temozolomide—melanoma	0.000295	0.00371	CcSEcCtD
Bleomycin—Haemoglobin—Carmustine—melanoma	0.000282	0.00356	CcSEcCtD
Bleomycin—Haemorrhage—Carmustine—melanoma	0.000281	0.00354	CcSEcCtD
Bleomycin—Hypoaesthesia—Carmustine—melanoma	0.000279	0.00352	CcSEcCtD
Bleomycin—Flushing—Dactinomycin—melanoma	0.000278	0.00351	CcSEcCtD
Bleomycin—Hypersensitivity—Vemurafenib—melanoma	0.000278	0.0035	CcSEcCtD
Bleomycin—Haemoglobin—Temozolomide—melanoma	0.000273	0.00344	CcSEcCtD
Bleomycin—Haemorrhage—Temozolomide—melanoma	0.000271	0.00342	CcSEcCtD
Bleomycin—Asthenia—Vemurafenib—melanoma	0.000271	0.00341	CcSEcCtD
Bleomycin—Hypoaesthesia—Temozolomide—melanoma	0.00027	0.0034	CcSEcCtD
Bleomycin—Chills—Dactinomycin—melanoma	0.000269	0.00339	CcSEcCtD
Bleomycin—Pruritus—Vemurafenib—melanoma	0.000267	0.00336	CcSEcCtD
Bleomycin—Alopecia—Dactinomycin—melanoma	0.000265	0.00334	CcSEcCtD
Bleomycin—Erythema—Dactinomycin—melanoma	0.000261	0.00329	CcSEcCtD
Bleomycin—Flushing—Carmustine—melanoma	0.00026	0.00328	CcSEcCtD
Bleomycin—Flushing—Temozolomide—melanoma	0.000252	0.00317	CcSEcCtD
Bleomycin—Alopecia—Carmustine—melanoma	0.000248	0.00313	CcSEcCtD
Bleomycin—Erythema—Carmustine—melanoma	0.000244	0.00308	CcSEcCtD
Bleomycin—Chills—Temozolomide—melanoma	0.000243	0.00307	CcSEcCtD
Bleomycin—Ill-defined disorder—Dactinomycin—melanoma	0.000242	0.00305	CcSEcCtD
Bleomycin—Anaemia—Dactinomycin—melanoma	0.000241	0.00304	CcSEcCtD
Bleomycin—Vomiting—Vemurafenib—melanoma	0.00024	0.00302	CcSEcCtD
Bleomycin—Alopecia—Temozolomide—melanoma	0.00024	0.00302	CcSEcCtD
Bleomycin—Rash—Vemurafenib—melanoma	0.000238	0.003	CcSEcCtD
Bleomycin—Dermatitis—Vemurafenib—melanoma	0.000238	0.00299	CcSEcCtD
Bleomycin—Erythema—Temozolomide—melanoma	0.000236	0.00298	CcSEcCtD
Bleomycin—Malaise—Dactinomycin—melanoma	0.000235	0.00297	CcSEcCtD
Bleomycin—Leukopenia—Dactinomycin—melanoma	0.000234	0.00295	CcSEcCtD
Bleomycin—Anaemia—Carmustine—melanoma	0.000226	0.00285	CcSEcCtD
Bleomycin—Nausea—Vemurafenib—melanoma	0.000224	0.00282	CcSEcCtD
Bleomycin—Myalgia—Dactinomycin—melanoma	0.000222	0.0028	CcSEcCtD
Bleomycin—Bronchospasm—Docetaxel—melanoma	0.000222	0.00279	CcSEcCtD
Bleomycin—Discomfort—Dactinomycin—melanoma	0.00022	0.00277	CcSEcCtD
Bleomycin—Ill-defined disorder—Temozolomide—melanoma	0.000219	0.00276	CcSEcCtD
Bleomycin—Leukopenia—Carmustine—melanoma	0.000219	0.00276	CcSEcCtD
Bleomycin—Anaemia—Temozolomide—melanoma	0.000218	0.00275	CcSEcCtD
Bleomycin—Pancytopenia—Docetaxel—melanoma	0.000214	0.0027	CcSEcCtD
Bleomycin—Oedema—Dactinomycin—melanoma	0.000213	0.00269	CcSEcCtD
Bleomycin—Malaise—Temozolomide—melanoma	0.000213	0.00268	CcSEcCtD
Bleomycin—Infection—Dactinomycin—melanoma	0.000212	0.00267	CcSEcCtD
Bleomycin—Leukopenia—Temozolomide—melanoma	0.000211	0.00266	CcSEcCtD
Bleomycin—Thrombocytopenia—Dactinomycin—melanoma	0.000209	0.00263	CcSEcCtD
Bleomycin—Chest pain—Carmustine—melanoma	0.000208	0.00262	CcSEcCtD
Bleomycin—Myalgia—Carmustine—melanoma	0.000208	0.00262	CcSEcCtD
Bleomycin—Cough—Temozolomide—melanoma	0.000206	0.0026	CcSEcCtD
Bleomycin—Weight decreased—Docetaxel—melanoma	0.000204	0.00257	CcSEcCtD
Bleomycin—Anorexia—Dactinomycin—melanoma	0.000203	0.00256	CcSEcCtD
Bleomycin—Pneumonia—Docetaxel—melanoma	0.000202	0.00255	CcSEcCtD
Bleomycin—Confusional state—Carmustine—melanoma	0.000201	0.00253	CcSEcCtD
Bleomycin—Myalgia—Temozolomide—melanoma	0.000201	0.00253	CcSEcCtD
Bleomycin—Oedema—Carmustine—melanoma	0.000199	0.00251	CcSEcCtD
Bleomycin—Discomfort—Temozolomide—melanoma	0.000199	0.0025	CcSEcCtD
Bleomycin—Infection—Carmustine—melanoma	0.000198	0.0025	CcSEcCtD
Bleomycin—Acute coronary syndrome—Docetaxel—melanoma	0.000198	0.0025	CcSEcCtD
Bleomycin—Myocardial infarction—Docetaxel—melanoma	0.000197	0.00248	CcSEcCtD
Bleomycin—Stomatitis—Docetaxel—melanoma	0.000196	0.00247	CcSEcCtD
Bleomycin—Thrombocytopenia—Carmustine—melanoma	0.000195	0.00246	CcSEcCtD
Bleomycin—Confusional state—Temozolomide—melanoma	0.000194	0.00245	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000194	0.00245	CcSEcCtD
Bleomycin—Anaphylactic shock—Temozolomide—melanoma	0.000193	0.00243	CcSEcCtD
Bleomycin—Oedema—Temozolomide—melanoma	0.000193	0.00243	CcSEcCtD
Bleomycin—Infection—Temozolomide—melanoma	0.000191	0.00241	CcSEcCtD
Bleomycin—Anorexia—Carmustine—melanoma	0.00019	0.0024	CcSEcCtD
Bleomycin—Thrombocytopenia—Temozolomide—melanoma	0.000189	0.00238	CcSEcCtD
Bleomycin—Hypotension—Carmustine—melanoma	0.000186	0.00235	CcSEcCtD
Bleomycin—Decreased appetite—Dactinomycin—melanoma	0.000185	0.00233	CcSEcCtD
Bleomycin—Anorexia—Temozolomide—melanoma	0.000184	0.00232	CcSEcCtD
Bleomycin—Pain—Dactinomycin—melanoma	0.000182	0.0023	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Carmustine—melanoma	0.000182	0.00229	CcSEcCtD
Bleomycin—Haemoglobin—Docetaxel—melanoma	0.000181	0.00228	CcSEcCtD
Bleomycin—Haemorrhage—Docetaxel—melanoma	0.00018	0.00227	CcSEcCtD
Bleomycin—Hypoaesthesia—Docetaxel—melanoma	0.000179	0.00226	CcSEcCtD
Bleomycin—Paraesthesia—Carmustine—melanoma	0.000179	0.00226	CcSEcCtD
Bleomycin—Dyspnoea—Carmustine—melanoma	0.000178	0.00224	CcSEcCtD
Bleomycin—Feeling abnormal—Dactinomycin—melanoma	0.000176	0.00221	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000176	0.00221	CcSEcCtD
Bleomycin—Decreased appetite—Carmustine—melanoma	0.000173	0.00218	CcSEcCtD
Bleomycin—Paraesthesia—Temozolomide—melanoma	0.000173	0.00218	CcSEcCtD
Bleomycin—Dyspnoea—Temozolomide—melanoma	0.000172	0.00217	CcSEcCtD
Bleomycin—Pain—Carmustine—melanoma	0.000171	0.00215	CcSEcCtD
Bleomycin—Body temperature increased—Dactinomycin—melanoma	0.000168	0.00212	CcSEcCtD
Bleomycin—Decreased appetite—Temozolomide—melanoma	0.000168	0.00211	CcSEcCtD
Bleomycin—Flushing—Docetaxel—melanoma	0.000167	0.00211	CcSEcCtD
Bleomycin—Pain—Temozolomide—melanoma	0.000165	0.00208	CcSEcCtD
Bleomycin—Feeling abnormal—Carmustine—melanoma	0.000164	0.00207	CcSEcCtD
Bleomycin—Chills—Docetaxel—melanoma	0.000162	0.00204	CcSEcCtD
Bleomycin—Alopecia—Docetaxel—melanoma	0.000159	0.00201	CcSEcCtD
Bleomycin—Feeling abnormal—Temozolomide—melanoma	0.000159	0.002	CcSEcCtD
Bleomycin—Body temperature increased—Carmustine—melanoma	0.000158	0.00199	CcSEcCtD
Bleomycin—Erythema—Docetaxel—melanoma	0.000157	0.00198	CcSEcCtD
Bleomycin—Hypersensitivity—Dactinomycin—melanoma	0.000157	0.00198	CcSEcCtD
Bleomycin—Urticaria—Temozolomide—melanoma	0.000153	0.00193	CcSEcCtD
Bleomycin—Asthenia—Dactinomycin—melanoma	0.000153	0.00193	CcSEcCtD
Bleomycin—Body temperature increased—Temozolomide—melanoma	0.000152	0.00192	CcSEcCtD
Bleomycin—Hypersensitivity—Carmustine—melanoma	0.000147	0.00185	CcSEcCtD
Bleomycin—Anaemia—Docetaxel—melanoma	0.000145	0.00183	CcSEcCtD
Bleomycin—Asthenia—Carmustine—melanoma	0.000143	0.0018	CcSEcCtD
Bleomycin—Hypersensitivity—Temozolomide—melanoma	0.000142	0.00179	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—ITGB1—melanoma	0.000142	0.0011	CbGpPWpGaD
Bleomycin—BLMH—Immune System—LGALS3—melanoma	0.000141	0.00109	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000141	0.00109	CbGpPWpGaD
Bleomycin—Leukopenia—Docetaxel—melanoma	0.000141	0.00177	CcSEcCtD
Bleomycin—LIG1—S Phase—RB1—melanoma	0.000139	0.00108	CbGpPWpGaD
Bleomycin—Asthenia—Temozolomide—melanoma	0.000138	0.00174	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—ERBB4—melanoma	0.000138	0.00107	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000138	0.00107	CbGpPWpGaD
Bleomycin—Cough—Docetaxel—melanoma	0.000137	0.00173	CcSEcCtD
Bleomycin—Pruritus—Temozolomide—melanoma	0.000136	0.00172	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000136	0.00106	CbGpPWpGaD
Bleomycin—Vomiting—Dactinomycin—melanoma	0.000135	0.00171	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000135	0.00105	CbGpPWpGaD
Bleomycin—Rash—Dactinomycin—melanoma	0.000134	0.00169	CcSEcCtD
Bleomycin—Myalgia—Docetaxel—melanoma	0.000134	0.00168	CcSEcCtD
Bleomycin—Chest pain—Docetaxel—melanoma	0.000134	0.00168	CcSEcCtD
Bleomycin—BLMH—Immune System—IFIH1—melanoma	0.000133	0.00104	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000132	0.00103	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD86—melanoma	0.000132	0.00103	CbGpPWpGaD
Bleomycin—LIG1—Synthesis of DNA—CDKN1B—melanoma	0.000132	0.00102	CbGpPWpGaD
Bleomycin—LIG1—Disease—HS3ST5—melanoma	0.000131	0.00102	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.00013	0.00101	CbGpPWpGaD
Bleomycin—Confusional state—Docetaxel—melanoma	0.000129	0.00163	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FGF1—melanoma	0.000128	0.000995	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD8A—melanoma	0.000128	0.000995	CbGpPWpGaD
Bleomycin—Anaphylactic shock—Docetaxel—melanoma	0.000128	0.00162	CcSEcCtD
Bleomycin—Oedema—Docetaxel—melanoma	0.000128	0.00162	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000128	0.00099	CbGpPWpGaD
Bleomycin—Infection—Docetaxel—melanoma	0.000127	0.0016	CcSEcCtD
Bleomycin—Vomiting—Carmustine—melanoma	0.000127	0.0016	CcSEcCtD
Bleomycin—Nausea—Dactinomycin—melanoma	0.000127	0.0016	CcSEcCtD
Bleomycin—Rash—Carmustine—melanoma	0.000126	0.00158	CcSEcCtD
Bleomycin—Dermatitis—Carmustine—melanoma	0.000126	0.00158	CcSEcCtD
Bleomycin—Thrombocytopenia—Docetaxel—melanoma	0.000125	0.00158	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000125	0.000971	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PDGFRA—melanoma	0.000124	0.000964	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—CDKN1B—melanoma	0.000124	0.000959	CbGpPWpGaD
Bleomycin—BLMH—Immune System—TLR3—melanoma	0.000123	0.000958	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—HLA-B—melanoma	0.000123	0.000957	CbGpPWpGaD
Bleomycin—Vomiting—Temozolomide—melanoma	0.000123	0.00154	CcSEcCtD
Bleomycin—Anorexia—Docetaxel—melanoma	0.000122	0.00154	CcSEcCtD
Bleomycin—LIG1—Synthesis of DNA—CDKN1A—melanoma	0.000122	0.000944	CbGpPWpGaD
Bleomycin—Rash—Temozolomide—melanoma	0.000121	0.00153	CcSEcCtD
Bleomycin—Dermatitis—Temozolomide—melanoma	0.000121	0.00153	CcSEcCtD
Bleomycin—LIG1—HIV Infection—ERCC2—melanoma	0.000121	0.000941	CbGpPWpGaD
Bleomycin—BLMH—Immune System—SKP2—melanoma	0.000121	0.000937	CbGpPWpGaD
Bleomycin—Hypotension—Docetaxel—melanoma	0.00012	0.00151	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000119	0.000922	CbGpPWpGaD
Bleomycin—Nausea—Carmustine—melanoma	0.000118	0.00149	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000117	0.00147	CcSEcCtD
Bleomycin—Paraesthesia—Docetaxel—melanoma	0.000115	0.00145	CcSEcCtD
Bleomycin—Nausea—Temozolomide—melanoma	0.000114	0.00144	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—HLA-A—melanoma	0.000114	0.000887	CbGpPWpGaD
Bleomycin—Dyspnoea—Docetaxel—melanoma	0.000114	0.00144	CcSEcCtD
Bleomycin—LIG1—DNA Replication—CDKN1A—melanoma	0.000114	0.000885	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—RAC1—melanoma	0.000114	0.000884	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—HLA-A—melanoma	0.000114	0.000882	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PTK2B—melanoma	0.000113	0.000881	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—RAC1—melanoma	0.000113	0.00088	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HSPA5—melanoma	0.000113	0.000876	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000113	0.000875	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000112	0.000871	CbGpPWpGaD
Bleomycin—Decreased appetite—Docetaxel—melanoma	0.000111	0.0014	CcSEcCtD
Bleomycin—BLMH—Immune System—GAB2—melanoma	0.00011	0.000857	CbGpPWpGaD
Bleomycin—Pain—Docetaxel—melanoma	0.00011	0.00138	CcSEcCtD
Bleomycin—LIG1—S Phase—CDKN1B—melanoma	0.000108	0.000839	CbGpPWpGaD
Bleomycin—LIG1—HIV Life Cycle—CD4—melanoma	0.000106	0.000823	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—SKP2—melanoma	0.000106	0.000821	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000106	0.00082	CbGpPWpGaD
Bleomycin—Feeling abnormal—Docetaxel—melanoma	0.000106	0.00133	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000104	0.000811	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—HLA-DRB1—melanoma	0.000104	0.00081	CbGpPWpGaD
Bleomycin—BLMH—Immune System—FOXO4—melanoma	0.000104	0.000805	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CCND1—melanoma	0.000103	0.0008	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD44—melanoma	0.000103	0.000796	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ITGA4—melanoma	0.000103	0.000796	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IFNB1—melanoma	0.000102	0.000791	CbGpPWpGaD
Bleomycin—Body temperature increased—Docetaxel—melanoma	0.000101	0.00128	CcSEcCtD
Bleomycin—BLMH—Immune System—CTLA4—melanoma	0.000101	0.000785	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—ICAM1—melanoma	0.0001	0.000778	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CDKN1A—melanoma	9.97e-05	0.000774	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IFNA1—melanoma	9.94e-05	0.000771	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	9.84e-05	0.000764	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	9.68e-05	0.000751	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—AURKA—melanoma	9.67e-05	0.00075	CbGpPWpGaD
Bleomycin—BLMH—Immune System—SYK—melanoma	9.65e-05	0.000749	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD80—melanoma	9.65e-05	0.000749	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—KIT—melanoma	9.63e-05	0.000747	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MLH1—melanoma	9.56e-05	0.000742	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—EGF—melanoma	9.52e-05	0.000739	CbGpPWpGaD
Bleomycin—BLMH—Immune System—AKT3—melanoma	9.47e-05	0.000735	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ITGAV—melanoma	9.47e-05	0.000735	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—SKP2—melanoma	9.45e-05	0.000734	CbGpPWpGaD
Bleomycin—Hypersensitivity—Docetaxel—melanoma	9.44e-05	0.00119	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	9.35e-05	0.000726	CbGpPWpGaD
Bleomycin—LIG1—Disease—CUL3—melanoma	9.34e-05	0.000725	CbGpPWpGaD
Bleomycin—LIG1—Disease—TRRAP—melanoma	9.34e-05	0.000725	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IFNA2—melanoma	9.25e-05	0.000718	CbGpPWpGaD
Bleomycin—Asthenia—Docetaxel—melanoma	9.19e-05	0.00116	CcSEcCtD
Bleomycin—LIG1—Disease—AKR1B10—melanoma	9.08e-05	0.000705	CbGpPWpGaD
Bleomycin—Pruritus—Docetaxel—melanoma	9.07e-05	0.00114	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	8.9e-05	0.00069	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CDH1—melanoma	8.86e-05	0.000688	CbGpPWpGaD
Bleomycin—BLMH—Immune System—SOCS1—melanoma	8.77e-05	0.000681	CbGpPWpGaD
Bleomycin—BLMH—Immune System—S100B—melanoma	8.75e-05	0.000679	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—AURKA—melanoma	8.65e-05	0.000671	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ITGB1—melanoma	8.6e-05	0.000667	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CD—melanoma	8.46e-05	0.000657	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	8.45e-05	0.000656	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—APEX1—melanoma	8.4e-05	0.000652	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ERBB4—melanoma	8.37e-05	0.000649	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	8.32e-05	0.000646	CbGpPWpGaD
Bleomycin—LIG1—S Phase—MYC—melanoma	8.27e-05	0.000642	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	8.21e-05	0.000637	CbGpPWpGaD
Bleomycin—Vomiting—Docetaxel—melanoma	8.15e-05	0.00103	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FGF2—melanoma	8.1e-05	0.000629	CbGpPWpGaD
Bleomycin—LIG1—Disease—LUM—melanoma	8.1e-05	0.000628	CbGpPWpGaD
Bleomycin—Rash—Docetaxel—melanoma	8.08e-05	0.00102	CcSEcCtD
Bleomycin—Dermatitis—Docetaxel—melanoma	8.07e-05	0.00102	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	8.02e-05	0.000623	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD86—melanoma	8.02e-05	0.000622	CbGpPWpGaD
Bleomycin—LIG1—Disease—HPSE—melanoma	7.94e-05	0.000616	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HGF—melanoma	7.87e-05	0.00061	CbGpPWpGaD
Bleomycin—LIG1—Disease—CUBN—melanoma	7.79e-05	0.000605	CbGpPWpGaD
Bleomycin—BLMH—Immune System—FGF1—melanoma	7.78e-05	0.000604	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CSF2—melanoma	7.78e-05	0.000604	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD8A—melanoma	7.78e-05	0.000604	CbGpPWpGaD
Bleomycin—Nausea—Docetaxel—melanoma	7.61e-05	0.000959	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	7.6e-05	0.00059	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—MDM2—melanoma	7.58e-05	0.000588	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PDGFRA—melanoma	7.53e-05	0.000585	CbGpPWpGaD
Bleomycin—LIG1—Disease—CSPG4—melanoma	7.53e-05	0.000584	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—APEX1—melanoma	7.51e-05	0.000583	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HLA-B—melanoma	7.48e-05	0.000581	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—ERBB2—melanoma	7.48e-05	0.00058	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PRKCA—melanoma	7.46e-05	0.000579	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	7.45e-05	0.000578	CbGpPWpGaD
Bleomycin—LIG1—Disease—RPS3—melanoma	7.4e-05	0.000575	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CB—melanoma	7.38e-05	0.000573	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD4—melanoma	7.36e-05	0.000571	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—CD4—melanoma	7.33e-05	0.000569	CbGpPWpGaD
Bleomycin—LIG1—Disease—SKI—melanoma	7.29e-05	0.000566	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MAP2K2—melanoma	7.29e-05	0.000566	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2B—melanoma	7.26e-05	0.000564	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	7.25e-05	0.000563	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	7.18e-05	0.000557	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	7.01e-05	0.000544	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	7e-05	0.000543	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	6.96e-05	0.00054	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HLA-A—melanoma	6.93e-05	0.000538	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CDKN1B—melanoma	6.92e-05	0.000537	CbGpPWpGaD
Bleomycin—BLMH—Immune System—RAC1—melanoma	6.91e-05	0.000536	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—E2F1—melanoma	6.67e-05	0.000517	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—PRKCA—melanoma	6.53e-05	0.000507	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN2B—melanoma	6.5e-05	0.000504	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CDKN1A—melanoma	6.39e-05	0.000496	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PTEN—melanoma	6.38e-05	0.000495	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—NFKB1—melanoma	6.34e-05	0.000492	CbGpPWpGaD
Bleomycin—BLMH—Immune System—TLR4—melanoma	6.34e-05	0.000492	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HLA-DRB1—melanoma	6.33e-05	0.000491	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	6.32e-05	0.000491	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—PCNA—melanoma	6.29e-05	0.000488	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ICAM1—melanoma	6.08e-05	0.000472	CbGpPWpGaD
Bleomycin—LIG1—Disease—HDAC6—melanoma	6.02e-05	0.000467	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.98e-05	0.000464	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—E2F1—melanoma	5.96e-05	0.000463	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD80—melanoma	5.85e-05	0.000454	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—PRKCA—melanoma	5.84e-05	0.000453	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KIT—melanoma	5.84e-05	0.000453	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	5.82e-05	0.000451	CbGpPWpGaD
Bleomycin—BLMH—Immune System—EGF—melanoma	5.77e-05	0.000448	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDK2—melanoma	5.75e-05	0.000446	CbGpPWpGaD
Bleomycin—LIG1—Disease—NPPA—melanoma	5.7e-05	0.000443	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	5.69e-05	0.000442	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	5.69e-05	0.000441	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—NRAS—melanoma	5.69e-05	0.000441	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—PCNA—melanoma	5.62e-05	0.000436	CbGpPWpGaD
Bleomycin—LIG1—Disease—VCAN—melanoma	5.57e-05	0.000432	CbGpPWpGaD
Bleomycin—LIG1—Disease—WNT5A—melanoma	5.52e-05	0.000429	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CASP8—melanoma	5.44e-05	0.000422	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDK4—melanoma	5.44e-05	0.000422	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TERT—melanoma	5.43e-05	0.000421	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	5.42e-05	0.00042	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CDH1—melanoma	5.37e-05	0.000417	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	5.37e-05	0.000417	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—EGFR—melanoma	5.18e-05	0.000402	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MAP2K1—melanoma	5.17e-05	0.000401	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDK2—melanoma	5.14e-05	0.000399	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CD—melanoma	5.13e-05	0.000398	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.94e-05	0.000383	CbGpPWpGaD
Bleomycin—BLMH—Immune System—FGF2—melanoma	4.92e-05	0.000381	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—KRAS—melanoma	4.9e-05	0.00038	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—ATM—melanoma	4.88e-05	0.000379	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDK4—melanoma	4.86e-05	0.000377	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.78e-05	0.000371	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—RB1—melanoma	4.73e-05	0.000367	CbGpPWpGaD
Bleomycin—BLMH—Immune System—BCL2—melanoma	4.67e-05	0.000362	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IFNG—melanoma	4.62e-05	0.000359	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MDM2—melanoma	4.6e-05	0.000357	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ERBB2—melanoma	4.53e-05	0.000352	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CA—melanoma	4.5e-05	0.000349	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CB—melanoma	4.47e-05	0.000347	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD4—melanoma	4.47e-05	0.000347	CbGpPWpGaD
Bleomycin—LIG1—Disease—GAB2—melanoma	4.44e-05	0.000344	CbGpPWpGaD
Bleomycin—LIG1—Disease—FASN—melanoma	4.34e-05	0.000337	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—RB1—melanoma	4.23e-05	0.000328	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CDKN1B—melanoma	4.2e-05	0.000326	CbGpPWpGaD
Bleomycin—LIG1—Disease—FOXO4—melanoma	4.17e-05	0.000324	CbGpPWpGaD
Bleomycin—LIG1—Disease—CXCR4—melanoma	4.17e-05	0.000324	CbGpPWpGaD
Bleomycin—LIG1—Disease—HDAC2—melanoma	4.17e-05	0.000324	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—HRAS—melanoma	4.16e-05	0.000323	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2A—melanoma	4.15e-05	0.000322	CbGpPWpGaD
Bleomycin—LIG1—Disease—CD44—melanoma	4.12e-05	0.00032	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL2—melanoma	4.11e-05	0.000319	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.03e-05	0.000313	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CTNNB1—melanoma	3.97e-05	0.000308	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CDKN1A—melanoma	3.88e-05	0.000301	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PTEN—melanoma	3.87e-05	0.0003	CbGpPWpGaD
Bleomycin—BLMH—Immune System—NFKB1—melanoma	3.85e-05	0.000299	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT3—melanoma	3.81e-05	0.000295	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN2A—melanoma	3.71e-05	0.000288	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN1B—melanoma	3.68e-05	0.000286	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—AKT1—melanoma	3.67e-05	0.000285	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MDM2—melanoma	3.6e-05	0.00028	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCND1—melanoma	3.51e-05	0.000272	CbGpPWpGaD
Bleomycin—BLMH—Immune System—STAT3—melanoma	3.46e-05	0.000268	CbGpPWpGaD
Bleomycin—BLMH—Immune System—NRAS—melanoma	3.45e-05	0.000268	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN1A—melanoma	3.4e-05	0.000264	CbGpPWpGaD
Bleomycin—LIG1—Disease—ERBB4—melanoma	3.36e-05	0.000261	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN2B—melanoma	3.33e-05	0.000259	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MAPK3—melanoma	3.3e-05	0.000256	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN1B—melanoma	3.29e-05	0.000255	CbGpPWpGaD
Bleomycin—LIG1—Disease—CD86—melanoma	3.22e-05	0.00025	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MAPK1—melanoma	3.14e-05	0.000244	CbGpPWpGaD
Bleomycin—BLMH—Immune System—EGFR—melanoma	3.14e-05	0.000244	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CCND1—melanoma	3.14e-05	0.000244	CbGpPWpGaD
Bleomycin—LIG1—Disease—FGF1—melanoma	3.13e-05	0.000243	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN1A—melanoma	3.04e-05	0.000236	CbGpPWpGaD
Bleomycin—LIG1—Disease—PDGFRA—melanoma	3.03e-05	0.000235	CbGpPWpGaD
Bleomycin—LIG1—Disease—PRKCA—melanoma	3e-05	0.000233	CbGpPWpGaD
Bleomycin—LIG1—Disease—ERCC2—melanoma	2.97e-05	0.000231	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KRAS—melanoma	2.97e-05	0.00023	CbGpPWpGaD
Bleomycin—LIG1—Disease—MAP2K2—melanoma	2.93e-05	0.000227	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—MAPK3—melanoma	2.89e-05	0.000225	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—MYC—melanoma	2.82e-05	0.000218	CbGpPWpGaD
Bleomycin—LIG1—Disease—HLA-A—melanoma	2.79e-05	0.000216	CbGpPWpGaD
Bleomycin—LIG1—Disease—TERT—melanoma	2.79e-05	0.000216	CbGpPWpGaD
Bleomycin—LIG1—Disease—RAC1—melanoma	2.78e-05	0.000216	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—MAPK1—melanoma	2.75e-05	0.000214	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CA—melanoma	2.73e-05	0.000212	CbGpPWpGaD
Bleomycin—LIG1—Disease—HIF1A—melanoma	2.66e-05	0.000207	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MAPK3—melanoma	2.59e-05	0.000201	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HRAS—melanoma	2.52e-05	0.000196	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MYC—melanoma	2.52e-05	0.000195	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MAPK1—melanoma	2.46e-05	0.000191	CbGpPWpGaD
Bleomycin—LIG1—Disease—NOS2—melanoma	2.42e-05	0.000188	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL6—melanoma	2.42e-05	0.000187	CbGpPWpGaD
Bleomycin—LIG1—Disease—NOTCH1—melanoma	2.4e-05	0.000186	CbGpPWpGaD
Bleomycin—LIG1—Disease—CD80—melanoma	2.35e-05	0.000182	CbGpPWpGaD
Bleomycin—LIG1—Disease—APC—melanoma	2.35e-05	0.000182	CbGpPWpGaD
Bleomycin—LIG1—Disease—KIT—melanoma	2.35e-05	0.000182	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGF—melanoma	2.32e-05	0.00018	CbGpPWpGaD
Bleomycin—BLMH—Immune System—AKT1—melanoma	2.23e-05	0.000173	CbGpPWpGaD
Bleomycin—LIG1—Disease—BRAF—melanoma	2.21e-05	0.000171	CbGpPWpGaD
Bleomycin—LIG1—Disease—MAP2K1—melanoma	2.08e-05	0.000161	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TP53—melanoma	2.07e-05	0.00016	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CD—melanoma	2.06e-05	0.00016	CbGpPWpGaD
Bleomycin—LIG1—Disease—FGF2—melanoma	1.98e-05	0.000153	CbGpPWpGaD
Bleomycin—LIG1—Disease—MDM2—melanoma	1.85e-05	0.000143	CbGpPWpGaD
Bleomycin—LIG1—Disease—ERBB2—melanoma	1.82e-05	0.000141	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CB—melanoma	1.8e-05	0.00014	CbGpPWpGaD
Bleomycin—LIG1—Disease—CD4—melanoma	1.8e-05	0.000139	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTGS2—melanoma	1.78e-05	0.000138	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN1B—melanoma	1.69e-05	0.000131	CbGpPWpGaD
Bleomycin—LIG1—Disease—CTNNB1—melanoma	1.59e-05	0.000124	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN1A—melanoma	1.56e-05	0.000121	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTEN—melanoma	1.55e-05	0.000121	CbGpPWpGaD
Bleomycin—LIG1—Disease—STAT3—melanoma	1.39e-05	0.000108	CbGpPWpGaD
Bleomycin—LIG1—Disease—NRAS—melanoma	1.39e-05	0.000108	CbGpPWpGaD
Bleomycin—LIG1—Disease—MAPK3—melanoma	1.33e-05	0.000103	CbGpPWpGaD
Bleomycin—LIG1—Disease—MYC—melanoma	1.29e-05	0.0001	CbGpPWpGaD
Bleomycin—LIG1—Disease—MAPK1—melanoma	1.26e-05	9.8e-05	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGFR—melanoma	1.26e-05	9.8e-05	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—melanoma	1.19e-05	9.26e-05	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CA—melanoma	1.1e-05	8.51e-05	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—melanoma	1.01e-05	7.87e-05	CbGpPWpGaD
Bleomycin—LIG1—Disease—IL6—melanoma	9.71e-06	7.53e-05	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT1—melanoma	8.96e-06	6.95e-05	CbGpPWpGaD
